SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Sundstrom Johan)
 

Sökning: WFRF:(Sundstrom Johan) > Amyloid β-protein, ...

Amyloid β-protein, Cystatin C and Cathepsin B as Biomarkers of Alzheimer's Disease

Sundelöf, Johan, 1974- (författare)
Uppsala universitet,Geriatrik
Lannfelt, Lars, Professor (preses)
Uppsala universitet,Geriatrik
Kilander, Lena, Docent (preses)
Uppsala universitet,Geriatrik
visa fler...
Basun, Hans, Professor (preses)
Uppsala universitet,Geriatrik
Sundstrom, Johan, Docent (preses)
Uppsala universitet,Institutionen för medicinska vetenskaper
Fratiglioni, Laura, Professor (opponent)
Karolinska Institutet, Institutionen för neurobiologi, vårdvetenskap och samhälle (NVS)
visa färre...
 (creator_code:org_t)
ISBN 9789155479565
Uppsala : Acta Universitatis Upsaliensis, 2010
Engelska 64 s.
Serie: Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 1651-6206 ; 626
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)
Abstract Ämnesord
Stäng  
  • It is suggested that Alzheimer’s disease (AD) is caused by an imbalance between production, degradation and clearance of the amyloid-β (Aβ) protein. This imbalance leads to aggregation of Aβ and tau proteins and neurodegeneration in the brain. Today there is increasing evidence that the balance between the protease cathepsin B and the protease inhibitor cystatin C affects the tendency for Aβ to aggregate. The primary aim of this thesis was to investigate Aβ, cystatin C and cathepsin B levels in blood and cerebro-spinal fluid (CSF) in relation to the risk of AD.Studies I & II were based on the re-examinations of participants, at ages 70 and 77, in the Uppsala Longitudinal Study of Adult Men (ULSAM), a community-based prospective study initiated in 1970 (participants then being 50 years of age). In ULSAM, low plasma Aβ1-40 (Study I) and low serum cystatin C levels (Study II) were associated with a higher risk of AD. Studies III & IV were based on a cross-sectional sample of people with AD, mild cognitive impairment and healthy controls, recruited at three Swedish Memory Disorder units: Uppsala University Hospital, Uppsala, Skåne University Hospital, Malmö, and Karolinska University Hospital, Huddinge, Stockholm. In Study III, CSF cystatin C levels were positively correlated with both Aβ1-42 and tau levels. In Study IV, individuals with AD had higher mean plasma cathepsin B levels than healthy controls.In conclusion, low plasma Aβ1-40 and low serum cystatin C levels may precede clinically manifest AD in elderly men, cystatin C levels are positively correlated with Aβ1-42 and tau levels in CSF, and mean plasma cathepsin B levels are higher in people with AD compared to healthy controls. In addition to Aβ1-42 and tau levels in CSF, Aβ1-40, cystatin C and cathepsin B levels in blood may reflect the risk of AD.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Geriatrik (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Geriatrics (hsv//eng)

Nyckelord

Alzheimer´s disease
amyloid β-protein
cystatin C
cathepsin B
biomarkers
risk factors
epidemiology
Geriatrics and medical gerontology
Geriatrik och medicinsk gerontologi
Medicin
Medicine

Publikations- och innehållstyp

vet (ämneskategori)
dok (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy